Oxygenta Pharmaceutical Limited (BOM:524636)

Oxygenta Pharmaceutical Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,195	2,942	971	520	342	74
Market Cap Growth	-29.37%	203.13%	86.75%	52.18%	358.63%	-
Enterprise Value	2,911	3,548	1,514	1,108	854	496
Last Close Price	59.36	79.56	28.99	36.60	24.05	7.30
PE Ratio	-	-	-	-	-	2.54
PS Ratio	1.96	2.69	2.45	1.68	0.56	0.14
PB Ratio	-5.99	-11.76	-4.82	-1.12	-0.99	-0.20
P/OCF Ratio	47.83	113.05	-	-	-	-
EV/Sales Ratio	2.60	3.25	3.82	3.58	1.41	0.95
EV/EBITDA Ratio	-	-	-	-	57.83	12.91
EV/EBIT Ratio	-	-	-	-	-	18.74
EV/FCF Ratio	-25.96	-	-	-	-	-
Debt / Equity Ratio	-1.99	-2.49	-2.84	-1.47	-1.50	-1.26
Debt / EBITDA Ratio	-	-	-	-	35.32	12.46
Asset Turnover	1.18	1.49	0.68	0.73	1.86	1.98
Inventory Turnover	5.67	6.26	3.19	3.17	5.82	5.17
Quick Ratio	0.14	0.11	0.29	0.31	0.22	0.12
Current Ratio	0.42	0.36	0.72	0.76	1.19	0.91
Return on Assets (ROA)	-11.97%	-8.82%	-13.14%	-13.41%	-0.22%	6.30%
Return on Invested Capital (ROIC)	-50.98%	-27.85%	-42.00%	-46.98%	-0.86%	-
Return on Capital Employed (ROCE)	220.20%	426.40%	-41.90%	-42.90%	-0.50%	16.20%
Earnings Yield	-7.52%	-3.29%	-3.58%	-22.26%	-1.79%	39.34%
FCF Yield	-5.11%	-2.99%	-17.67%	-21.70%	-19.40%	-112.30%
Buyback Yield / Dilution	-7.58%	-12.20%	-125.61%	-11.43%	-24.92%	-24.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.